NCT04206969

Brief Summary

The symptomatic and clinical expression of psychiatric disorders in children and adolescents is strongly influenced by the cultural setting they are growing up in. These cultural variations complicate psychiatric care, especially for migrant children, for whom appropriate care must be designed. Transcultural psychotherapy is an original psychotherapeutic technique developed to meet these specific requirements in France and in different European and American countries. Its theoretical and methodological foundations rest on the works of George Devereux in ethnopsychiatry (1970). A psychotherapeutic technique intended for first-generation migrants was developed by Tobie Nathan and coll (1986). Marie-Rose Moro and colleagues (1990) have adapted this technique to second-generation migrants. Indicated as a second-line treatment after the failure of standard management, this technique is fully formalized today. It comprises group consultations for the child and the family as a one-hour session each month, directed by a principal therapist, assisted by a group of co-therapists (of diverse cultural origins and occupations) and an interpreter in the family's mother tongue. The concept of culture is used to establish the therapeutic alliance, decode the symptoms, and propose treatment. The children and adolescents receiving this treatment have varied psychopathological profiles, mostly involving depressive and/or anxiety disorders. Specifically, migrants' children are especially vulnerable to depression, their psychiatric care is generally longer and less effective than in the general population, and their rate of treatment failure higher. Transcultural psychotherapy has demonstrated its value in these situations in numerous qualitative studies, but its efficacy has not yet been assessed by a method providing a high level of evidence, such as randomized controlled trials.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable major-depressive-disorder

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable major-depressive-disorder

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

October 28, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 6, 2025

Status Verified

March 1, 2025

Enrollment Period

3.5 years

First QC Date

December 16, 2019

Last Update Submit

April 4, 2025

Conditions

Keywords

Transcultural psychotherapymigrantchildadolescentDepressive Disorderpsychiatric caremixed studiesbayesian designqualitative studyRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Severity Score on the Improved Global Impression Scale (iCGI) to assess remission

    .iCGI score is a scale ranging from 1 to 7, 1 being Normal, not at all ill, and 7 - Among the most extremely ill patients. 1. \- Normal, not at all ill 2. \- Borderline mentally ill 3. \- Mildly ill 4. \- Moderately ill 5. \- Markedly ill 6. \- Severely ill 7. \- Among the most extremely ill patients Remission is defined as a mean iCGI score over the 3 experts \<4 at 28 weeks of treatment (W34).

    at week 34 visit (v5)

Secondary Outcomes (6)

  • Severity score on the iCGI

    at baseline and weeks 6, 13, 20, 27 and 34 and 52

  • Score on the French version of the Children's Depression Rating Scale-Revised (CDRS-R)

    at baseline and weeks 6, 13, 20, 27 and 34 and 52

  • Score on the French version of the State-Trait Anxiety Inventory for children (STAI-C)

    at baseline and weeks 6, 13, 20, 27 and 34 and 52

  • Score changes in Depression and anxiety Scores between Week 34 and week 52

    at 34 and 52 weeks

  • analysis of the content of the clinical data collected during the visits

    between 34 and 44 weeks

  • +1 more secondary outcomes

Study Arms (2)

Transcultural psychotherapy

EXPERIMENTAL

In addition to usual care, the participants in the treatment group receive transcultural psychotherapy in the inclusion centers, which consists of 5 sessions every 7 weeks (W6, W13, W20, W27, and W34). During all the research process, participants from both groups continue their usual care provided by the referent medical team outside the inclusion center.

Behavioral: Transcultural psychotherapy

standard care

NO INTERVENTION

usual care provided by the referent medical team

Interventions

In addition to usual care, the participants receive transcultural psychotherapy

Transcultural psychotherapy

Eligibility Criteria

Age6 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Be a child aged or an adolescent aged 6-20 years-old (this may be a declaratory age at the time of the consultation or based on a document for a residence request if no other identity documents are available)
  • Be a first or second-generation migrant (born abroad or born from at least one parent who is born abroad)
  • Have a psychological and/or psychiatric follow-up by a first-line care
  • Have been referred for transcultural psychotherapy by their first line care to treat depression resistant to standard management.
  • Present a depression according to the clinician who proposes the transcultural treatment (first line therapist), based on usual as well as cultural symptoms criteria of the below list:
  • Sadness
  • Diminish interest or pleasure in most of the usual activities
  • Insomnia or hypersomnia
  • Psychomotor agitation
  • Asthenia, loss of energy
  • Feeling of worthlessness or excessive guilt
  • Recurrent throughs of death
  • School problems (school failure, drop in grades, aggressivity with adult, school refusal…)
  • Mutism, and selective mutism
  • Runaways
  • +11 more criteria

You may not qualify if:

  • Patient or family has previously had transcultural psychotherapy
  • Patient presents an acute psychiatric disorder which hinders the realization of the transcultural therapy - for example, excited delirium with great psychic disorganization, or high suicidal risk patients. These situations will be excluded during the screening time based on the first line therapist evaluation
  • Patient presents an acute somatic disease which may hinder the well organization of the therapy
  • Patient addressed for a legal expertise
  • Child's/Adolescent's refusal
  • Pregnant or breastfeeding (for women for young women of childbearing age)
  • Participation in another interventional study
  • Patient under guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Service de Psychopathologie de l'enfant, de l'adolescent, CHU Avicenne

Bobigny, France

Location

Service de psychiatrie de l'enfant et de l'adolescent, CHRU Gabriel Montpied

Clermont-Ferrand, France

Location

Maison de Solenn, Cochin Hospital

Paris, 75000, France

Location

Centre Médico-psychologique, Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital La Grave, CHU Toulouse

Toulouse, France

Location

MeSH Terms

Conditions

Depressive Disorder, MajorDepressive Disorder

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Study Officials

  • Jonathan LACHAL, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2019

First Posted

December 20, 2019

Study Start

October 28, 2020

Primary Completion

April 29, 2024

Study Completion

May 1, 2025

Last Updated

April 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations